GFC Life Science Co., Ltd (KOSDAQ:388610)
South Korea · Delayed Price · Currency is KRW 18,770
-140 (-0.74%)
At close: Sep 17, 2025
GFC Life Science Revenue
In the year 2021, GFC Life Science had annual revenue of 13.74B KRW with 3.09% growth. GFC Life Science had revenue of 4.49B in the quarter ending June 30, 2025.
Revenue
13.74B
Revenue Growth
+3.09%
P/S Ratio
7.36
Revenue / Employee
n/a
Employees
n/a
Market Cap
101.12B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2021 | 13.74B | 412.37M | 3.09% |
| Dec 31, 2020 | 13.32B | 1.42B | 11.89% |
| Dec 31, 2019 | 11.91B | 3.23B | 37.21% |
| Dec 31, 2018 | 8.68B | 1.52B | 21.20% |
| Dec 31, 2017 | 7.16B | 154.44M | 2.20% |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.59T |
| SK hynix | 77.21T |
| LG Energy Solution | 25.16T |
| Samsung Biologics | 5,031.69B |
| Hanwha Aerospace | 19.25T |
| Hyundai Motor Company | 182.25T |
| HD Hyundai Heavy Industries | 15.58T |
| KB Financial Group | 14.92T |